You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Readers’ editor

David Payne: Digital dilemmas—a day in my life at The BMJ

12 Dec, 14 | by BMJ Group

deputy chair of MJA on stage (1)Wednesday December 10.

8.30am: I’m on the bus into work and checking Twitter when I see an exchange between @garyschwitzer and @bengoldacre about some embargoed papers we press released last night, (including Ben’s editorial and a linked research paper about the association between exaggeration in health related science news and academic press releases), not showing on thebmj.com.

I apologise to @garyschwitzer and explain why I think they aren’t working. more…

Readers’ editor: Inserts in the print issue

30 Sep, 14 | by BMJ Group

deputy chair of MJA on stage (1)If you shake the current print issue of The BMJ, a cluster of inserts fall to the ground, among them a wine club promotion, an online menswear retailer, and a charity appeal from the Refugee Council.

Sometimes readers do challenge the accuracy of information in these inserts, or question our decision to accept money from organisations whose views they do not agree with.

Last year, for example, a reader complained about an insert from the organisation Campaign for Dignity in Dying, which wants to legalise assisted dying in the UK, subject to certain safeguards. more…

The BMJ Today: Feet and fudge

25 Jul, 14 | by BMJ Group

davidpayneA calcaneal fracture can mean a two year recovery, with a stiff, painful, deformed foot that will not fit into a normal shoe.

How does operative and non-operative treatment for intra-articular fractures compare?

A research team led by Damian Griffin, professor of trauma and orthopaedic surgery at Warwick University Medical School, conclude in their randomised controlled trial that operative treatment by open reduction and internal fixation is not recommended. more…

The BMJ Today: Talking shit again

21 Jul, 14 | by BMJ Group

By the end of next month rural India could have an extra 5.2m toilets as part of a pre-election pledge by Narendra Modi, now prime minister, to build “toilets first and temples later.”

Readers of The BMJ will no doubt be heartened by the Indian government’s announcement, coming seven years after sanitation topped a reader poll as the greatest “medical milestone” in the past 166 years  more…

Readers’ editor: A website needing more soft fruit

20 Jul, 14 | by BMJ Group

davidpayneWe like it when readers take the time and trouble to give us feedback. We’ve been particularly appreciative in the last two weeks as The BMJ’s new website beds down following its launch on 30 June. Some readers responded to the editorial published to mark the new website and the journal’s new name and logo.  Eighty readers replied to an email we sent out about the new site. Others used our customer service feedback form, and contacted us directly via email. Last week we did our first technical release since the new site went live, and we used it to tweak the design (based on your feedback), implement some changes we couldn’t squeeze in before launch, and fix some bugs. more…

The BMJ Today: New name, new logo, new website, some bugs

1 Jul, 14 | by BMJ Group

davidpayneWriters of this daily update about new stuff published by The BMJ usually face an embarrassment of richesmore than 100 articles go online each week, along with dozens of rapid responses, video abstracts, and audio interviews. But yesterday hardly anything got published because we needed to clear the decks for a new website, which heralds the journal’s new name (The BMJ), new homepage address (thebmj.com), and logo (a dark blue “lozenge” in a lower case font). All this happened after 4pm British Summer Time. more…

Trish Groves: Media reaction to the updated Cochrane reviews on Tamiflu and Relenza

25 Apr, 14 | by BMJ Group

trish_grovesThe two updated Cochrane reviews on the benefits and harms in influenza of the neuraminidase inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza) attracted lots of attention after The BMJ published them earlier this month. This is my third blog about the feedback. The first blog focussed on rapid responses to the two research articles, and the second looked at how they were covered in the blogosphere. This final one examines the media coverage. more…

Trish Groves: How bloggers responded to the updated Cochrane reviews on Tamiflu and Relenza

24 Apr, 14 | by BMJ Group

trish_grovesMy earlier blog outlined BMJ reader feedback to the two updated Cochrane reviews on the benefits and harms in influenza of the neuraminidase inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza). But the two research articles also attracted a great deal of attention in the blogosphere. more…

Trish Groves: Reader responses to updated Cochrane reviews on Tamiflu and Relenza

23 Apr, 14 | by BMJ Group

trish_grovesIt’s nearly two weeks since The BMJ published two updated Cochrane reviews on the benefits and harms in influenza of the neuraminidase inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza). These research articles were accompanied by The BMJ’s peer review comments and other supplementary files and appendices and several commissioned articles. more…

Readers’ editor: Clichéd series titles, and “Save our Des”

11 Mar, 14 | by BMJ Group

David PayneLast month the journal launched the first in a series of in-depth reviews written by international experts—State of the Art—to highlight important areas of clinical medicine and academic inquiry.

So far we have published two. The first article examined the mechanisms and clinical implications of neuropathic pain and, according to Google Analytics, has been viewed 21,930 times since its publication on 5 February. It is the 10th most viewed page on bmj.com, and we hope it and subsequent articles steer “an effective course between oversimplification and over-complication,” to quote one reviewer. The second article looked at drug treatments for epilepsy in adults. It went online on 28 February, and so far has 11,418 views, our 19th most popular page. more…

BMJ blogs homepage

The BMJ

Helping doctors make better decisions. Visit site



Creative Comms logo

Latest from The BMJ

Latest from The BMJ

Latest from BMJ podcasts

Latest from BMJ podcasts

Blogs linking here

Blogs linking here